For the Inventor, By the Inventor

Enter assignee name

Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.

USPTO Granted Patents = 26

CIPO Patents = 1

EPO Patents = 12

Trademarks = 10

Forward Citations = 11

Loading Chart...

Loading Chart...

100 inventors (with patents filed for the assignee):

Jingyi Wang (26 out of 41 patents)

Lichun Wang (23 out of 30 patents)

Jiaqiang Cai (11 out of 12 patents)

4. Qiang Tian (11 out of 12 patents)

5. Tongtong Xue (11 out of 12 patents)

6. Hongmei Song (10 out of 12 patents)

7. Liang Xiao (10 out of 11 patents)

8. Hong Zeng (9 out of 11 patents)

9. Shuai Song (6 out of 7 patents)

10. Mingliang Zhao (5 out of 6 patents)

11. Dengnian Liu (5 out of 6 patents)

12. Dong Long (4 out of 4 patents)

13. Yongyong Wu (4 out of 4 patents)

14. Hanwen Deng (3 out of 4 patents)

15. Guoqing Zhong (3 out of 5 patents)

26 patents: Sort by Forward Citations

1. 12297265 - Antibody and use thereof (2025-05-13),

2. 12269816 - Benzothiophene compound, preparation method therefor and use thereof (2025-04-08),

3. 12258419 - Anti-FXI/FXIa antibody and use thereof (2025-03-25),

4. 12150944 - Use of anti-HER2 antibody-drug conjugate in cancer treatment (2024-11-26),

5. 11970506 - Bioactive molecule conjugate, preparation method and use thereof (2024-04-30),

6. 11903948 - Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof (2024-02-20),

7. 11667629 - Isoxazole derivative, preparation method therefor, and use thereof (2023-06-06),

8. 11655295 - Anti-LAG-3 antibody and use thereof (2023-05-23),

9. 11541049 - Tetrahydroisoquinoline derivatives, preparation process and use thereof (2023-01-03),

10. 11434235 - Solid form of dihydropyrimidine compound and preparation method therefor and use thereof (2022-09-06),

11. 11421029 - Recombinant bispecific antibodies to PD-L1 and CTLA-4 (2022-08-23),

12. 11332457 - Aromatic compound, pharmaceutical composition and use thereof (2022-05-17),

13. 11292785 - Nitrogen-containing benzoheterocycle compound comprising carboxylic acid group, preparation method and use thereof (2022-04-05),

14. 11266674 - Pharmaceutical composition for tumor treatment or prevention, method, and use thereof (2022-03-08),

15. 11261170 - Aromatic compound, pharmaceutical composition and use thereof (2022-03-01),

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company based in Sichuan, China. They specialize in the research, development, and manufacturing of high-quality biopharmaceutical products. With a strong focus on innovation and cutting-edge technology, Kelun-Biotech is committed to improving the health and well-being of people worldwide. Their diverse product portfolio includes vaccines, therapeutic proteins, and monoclonal antibodies, among others. Striving for excellence, Kelun-Biotech adheres to rigorous quality standards and continuously invests in research and development to bring breakthrough therapies to the market. For more information, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

26 Patents

#13 in Chengdu

#1,042 in China

#24,071 in the World

Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.

Forward Citations = 11

100 inventors:

Jingyi Wang (26 out of 41 patents)

Lichun Wang (23 out of 30 patents)

Jiaqiang Cai (11 out of 12 patents)

4. Qiang Tian (11 out of 12 patents)

5. Tongtong Xue (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…